South Korea Health Ministry Seeks Legal Grounds Against Doctor Kickbacks
This article was originally published in PharmAsia News
Executive Summary
SEOUL - One month after denying it would seek tightened legal restrictions and punishment for doctors who accept kickbacks from pharmaceutical companies, South Korea's Ministry for Health, Welfare and Family Affairs said April 6 it now supports a bill submitted to the National Assembly to suspend licenses of doctors who participate in the practice
You may also be interested in...
South Korea’s FTC Looking Into Sanofi Aventis and Novartis For Price Inflation – Industry Insiders
SEOUL - As South Korea's government agencies move to tighten surveillance on illegal and unfair deals in the pharma industry, the Fair Trade Commission is now looking into several companies including Sanofi-Aventis and Novartis to investigate inflated prices on their products which are considerably more expensive in South Korea than in other countries such as the U.S. and UK, according to industry insiders
South Korea’s FTC Looking Into Sanofi Aventis and Novartis For Price Inflation – Industry Insiders
SEOUL - As South Korea's government agencies move to tighten surveillance on illegal and unfair deals in the pharma industry, the Fair Trade Commission is now looking into several companies including Sanofi-Aventis and Novartis to investigate inflated prices on their products which are considerably more expensive in South Korea than in other countries such as the U.S. and UK, according to industry insiders
South Korean Health Ministry Hesitant To Punish Doctors For Accepting Pharma Rebates
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs denied a string of pharma industry expectations and local press reports that it was moving to tighten legal restrictions and punishments for doctors who accept rebates from pharmaceutical companies